Can You Pass the (Deoxyribonucleic) Acid Test?
By Center for Environmental Health,
Center for Environmental Health [with CGS's Pete Shanks]
| 03. 17. 2014
For just $99, genetic test company 23andme offered to test your DNA for everything from heart disease risk to your chance of going bald. Kira Peikoff wondered what DNA testing from 23andme and two other companies would tell her—and the results were surprising. We’ll also talk to geneticist Dr. David Ng. His story in McSweeny’s, “Congratulations, Your Ineffectual Genetic Test Results Have Arrived” pokes fun at the “direct-to-consumer” genetic testing industry. Then Dr. Stuart Newman fills us in on epigenetics, evolutionary developmental biology, and why the Lamarck versus Darwin debate may be old news. Finally, advocate Pete Shanks on the “promise” of GMO humans and the threat of techno-eugenics.
Check out this episode.
Download here, or subscribe via iTunes.
Kira Peikoff is an author and Masters student in bioethics at Columbia University. Her New York Times article in December exposed the fallacies of direct-to-consumer genetic testing (see more resources on genetic test companies below). Check out her debut novel Living Proof (and look for her upcoming 2nd novel in the fall) on her website.
David Ng is...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...